SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations
- PMID: 20577002
- DOI: 10.1136/jmg.2010.077180
SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations
Abstract
Background: Mutations in SOD1, ANG, VAPB, TARDBP and FUS genes have been identified in amyotrophic lateral sclerosis (ALS).
Methods: The relative contributions of the different mutations to ALS were estimated by systematically screening a cohort of 162 families enrolled in France and 500 controls (1000 chromosomes) using molecular analysis techniques and performing phenotype-genotype correlations.
Results: 31 pathogenic missense mutations were found in 36 patients (20 SOD1, 1 ANG, 1 VAPB, 7 TARDBP and 7 FUS). Surprisingly two FUS mutation carriers also harboured ANG variants. One family of Japanese origin with the P56S VAPB mutation was identified. Seven novel mutations (three in SOD1, two in TARDBP, two in FUS) were found. None of them was detected in controls. Segregation of detected mutations with the disease was confirmed in 11 families including five pedigrees carrying the novel mutations. Clinical comparison of SOD1, TARDBP, FUS and other familial ALS patients (with no mutation in the screened genes) revealed differences in site of onset (predominantly lower limbs for SOD1 and upper limbs for TARDBP mutations), age of onset (younger with FUS mutations), and in lifespan (shorter for FUS carriers). One third of SOD1 patients survived more than 7 years: these patients had earlier disease onset than those presenting with a more typical course. Differences were also observed among FUS mutations, with the R521H FUS mutation being associated with longer disease duration.
Conclusions: This study identifies new genetic associations with ALS and provides phenotype-genotype correlations with both previously reported and novel mutations.
Similar articles
-
SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: a United States clinical testing lab experience.Amyotroph Lateral Scler. 2012 Feb;13(2):217-22. doi: 10.3109/17482968.2011.643899. Amyotroph Lateral Scler. 2012. PMID: 22292843
-
FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS.Neurobiol Aging. 2011 Mar;32(3):553.e13-21. doi: 10.1016/j.neurobiolaging.2010.04.009. Epub 2010 May 15. Neurobiol Aging. 2011. PMID: 20472325
-
FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):639-45. doi: 10.1136/jnnp.2009.194399. Epub 2009 Dec 3. J Neurol Neurosurg Psychiatry. 2010. PMID: 19965854
-
TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update.Hum Mutat. 2013 Jun;34(6):812-26. doi: 10.1002/humu.22319. Epub 2013 Apr 29. Hum Mutat. 2013. PMID: 23559573 Review.
-
Genetics of familial Amyotrophic lateral sclerosis.Arch Ital Biol. 2011 Mar;149(1):65-82. doi: 10.4449/aib.v149i1.1262. Arch Ital Biol. 2011. PMID: 21412717 Review.
Cited by
-
Aging Disrupts the Circadian Patterns of Protein Expression in the Murine Hippocampus.Front Aging Neurosci. 2020 Jan 15;11:368. doi: 10.3389/fnagi.2019.00368. eCollection 2019. Front Aging Neurosci. 2020. PMID: 32009941 Free PMC article.
-
Clinical neurogenetics: amyotrophic lateral sclerosis.Neurol Clin. 2013 Nov;31(4):929-50. doi: 10.1016/j.ncl.2013.05.003. Neurol Clin. 2013. PMID: 24176417 Free PMC article. Review.
-
Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration.Mol Neurobiol. 2018 Aug;55(8):6480-6499. doi: 10.1007/s12035-017-0856-0. Epub 2018 Jan 10. Mol Neurobiol. 2018. PMID: 29322304 Review.
-
Genetic analysis in Chinese patients with familial or young-onset amyotrophic lateral sclerosis.Neurol Sci. 2022 Apr;43(4):2579-2587. doi: 10.1007/s10072-021-05634-z. Epub 2021 Sep 26. Neurol Sci. 2022. PMID: 34564799
-
TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP.J Neuropathol Exp Neurol. 2021 Feb 22;80(3):229-239. doi: 10.1093/jnen/nlaa162. J Neuropathol Exp Neurol. 2021. PMID: 33421065 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous